CY2020 Q4
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| FLOWSERVE CORP | $22,847,000.00 | 2020-12-31 | View |
| UNITED STATES ANTIMONY CORPORATION | $434,981.00 | 2020-12-31 | View |
| TELIGENT, INC. | $302,000.00 | 2020-12-31 | View |
| ELECTRONIC ARTS INC. | $274,000,000.00 | 2020-12-31 | View |
| ANIXA BIOSCIENCES, INC. | $577,190.00 | 2021-01-31 | View |
| LIGAND PHARMACEUTICALS INC | $693,000.00 | 2020-12-31 | View |
| MAGAL SECURITY SYSTEMS LTD | $1,940,000.00 | 2020-12-31 | View |
| Imageware Systems Inc | $72,000.00 | 2020-12-31 | View |
| CNX Resources Corporation | $72,401,000.00 | 2020-12-31 | View |
| TELKONET, INC. | $500,000.00 | 2020-12-31 | View |
| GRAN TIERRA ENERGY INC. | $1,570,000.00 | 2020-12-31 | View |
| ACCELERON PHARMA INC. | $1,191,000.00 | 2020-12-31 | View |
| BYRNA TECHNOLOGIES INC. | $268,000.00 | 2020-11-30 | View |
| NANOVIRICIDES, INC. | $0.00 | 2020-12-31 | View |
| OPIANT PHARMACEUTICALS, INC. | $1,908,000.00 | 2020-12-31 | View |
| MINIM, INC. | $1,906,439.00 | 2020-12-31 | View |
| AVALO THERAPEUTICS, INC. | $2,000,000.00 | 2020-12-31 | View |
| CHEMOMAB THERAPEUTICS LTD. | $0.00 | 2020-12-31 | View |
| NEXIMMUNE, INC. | $50,000.00 | 2020-12-31 | View |
| Sisecam Resources LP | $8,100,000.00 | 2020-12-31 | View |
| PV Nano Cell, Ltd. | $384.00 | 2020-12-31 | View |
| TREACE MEDICAL CONCEPTS, INC. | $1,032,000.00 | 2020-12-31 | View |
| Shattuck Labs, Inc. | $0.00 | 2020-12-31 | View |
| Moderna, Inc. | $0.00 | 2020-12-31 | View |
| TCR2 Therapeutics Inc. | $0.00 | 2020-12-31 | View |
| Dyne Therapeutics, Inc. | $0.00 | 2020-12-31 | View |
| Coeptis Therapeutics, Inc. | $583,333.00 | 2020-12-31 | View |
| INDIE SEMICONDUCTOR, INC. | $139,000.00 | 2020-12-31 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations